Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-11-25 00:09 | 2020-11-23 | VCEL | Vericel Corp | ZERBE ROBERT L MD | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $23.55 | 17,500 | $412,125 | 31,795 | -35.5% |
| 2020-06-24 23:19 | 2020-06-23 | VCEL | Vericel Corp | Halpin Michael | Officer; Chief Operating Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $15.01 | 14,751 | $221,413 | 1,622 | -90.1% |
| 2020-06-18 23:03 | 2020-06-16 | VCEL | Vericel Corp | Halpin Michael | Officer; Chief Operating Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $15.00 | 4,002 | $60,030 | 1,622 | -71.2% |
| 2019-11-13 00:03 | 2019-11-11 | VCEL | Vericel Corp | Halpin Michael | Officer; Chief Operating Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $18.53 | 15,047 | $278,821 | 1,034 | -93.6% |
| 2019-10-03 23:03 | 2019-10-01 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $14.88 | 58,125 | $864,650 | 112,783 | -34.0% |
| 2019-08-16 23:06 | 2019-08-14 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $16.62 | 17,000 | $282,547 | 123,182 | -12.1% |
| 2019-07-17 23:17 | 2019-07-15 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $19.68 | 17,000 | $334,579 | 123,182 | -12.1% |
| 2019-06-12 23:07 | 2019-06-10 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $15.62 | 17,500 | $273,373 | 122,672 | -12.5% |
| 2019-05-14 23:23 | 2019-05-13 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $17.02 | 17,500 | $297,859 | 122,672 | -12.5% |
| 2019-05-03 23:07 | 2019-05-01 | VCEL | Vericel Corp | GILMAN STEVEN C | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $16.81 | 7,500 | $126,095 | 0 | -100.0% |
| 2019-04-10 23:12 | 2019-04-08 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $17.64 | 15,625 | $275,592 | 122,672 | -11.3% |
| 2019-03-12 23:12 | 2019-03-11 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | SALE | $20.02 | 10,000 | $200,235 | 122,249 | -7.6% |
| 2019-03-05 00:01 | 2019-02-28 | VCEL | Vericel Corp | GILMAN STEVEN C | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $18.02 | 7,500 | $135,129 | 0 | -100.0% |
| 2019-02-14 00:16 | 2019-02-11 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | SALE | $17.09 | 10,000 | $170,880 | 132,249 | -7.0% |
| 2019-01-17 00:00 | 2019-01-14 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | SALE | $17.18 | 8,711 | $149,627 | 142,249 | -5.8% |
| 2019-01-05 00:13 | 2019-01-02 | VCEL | Vericel Corp | Wotton Paul K | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $16.83 | 22,500 | $378,693 | 0 | -100.0% |
| 2018-12-13 00:06 | 2018-12-10 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $16.81 | 15,625 | $262,656 | 150,960 | -9.4% |
| 2018-12-05 00:05 | 2018-12-03 | VCEL | Vericel Corp | GILMAN STEVEN C | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $17.75 | 8,500 | $150,908 | 0 | -100.0% |
| 2018-11-15 00:03 | 2018-11-12 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $15.90 | 15,000 | $238,500 | 150,960 | -9.0% |
| 2018-11-09 00:02 | 2018-11-06 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $15.39 | 50,000 | $769,500 | 75,163 | -39.9% |
| 2018-10-17 23:05 | 2018-10-15 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $12.65 | 15,000 | $189,750 | 150,960 | -9.0% |
| 2018-10-09 23:03 | 2018-10-04 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $15.02 | 75,000 | $1,126,500 | 75,163 | -49.9% |
| 2018-09-12 20:57 | 2018-09-10 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $12.35 | 15,000 | $185,250 | 150,960 | -9.0% |
| 2018-09-06 23:05 | 2018-09-04 | VCEL | Vericel Corp | GILMAN STEVEN C | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $12.03 | 9,000 | $108,270 | 0 | -100.0% |
| 2018-06-20 21:05 | 2018-06-18 | VCEL | Vericel Corp | Wotton Paul K | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $12.06 | 30,000 | $361,800 | 0 | -100.0% |
| 2018-05-18 23:00 | 2018-05-16 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $14.01 | 28,886 | $404,603 | 73,559 | -28.2% |
| 2018-05-15 00:26 | 2018-05-10 | VCEL | Vericel Corp | Orlando Daniel | Officer; Chief Operating Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $13.04 | 34,183 | $445,856 | 12,518 | -73.2% |
| 2018-03-20 17:25 | 2018-03-16 | VCEL | Vericel Corp | Rubino Alan L | Director | Biological Products, (No Diagnostic Substances) | BUY | $11.57 | 890 | $10,296 | 40 | +100.0% |
| 2016-03-30 01:38 | 2016-03-28 | VCEL | Vericel Corp | Consonance Capital Management LP | 10% owner | Biological Products, (No Diagnostic Substances) | SALE | $5.39 | 120,000 | $646,800 | 2,232,940 | -5.1% |
| 2005-08-19 23:40 | 2005-08-17 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $2.79 | 358 | $999 | 7,927 | +4.7% |
| 2005-07-22 20:53 | 2005-07-20 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $3.12 | 320 | $998 | 7,568 | +4.4% |
| 2005-06-22 23:06 | 2005-06-22 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $2.82 | 354 | $998 | 7,248 | +5.1% |
| 2005-05-23 23:22 | 2005-05-20 | VCEL | Vericel Corp | ARMSTRONG R DOUGLAS PHD | Director, Officer; Chairman, CEO | Biological Products, (No Diagnostic Substances) | SALE | $2.86 | 120,173 | $344,079 | 501,746 | -19.3% |
| 2005-05-20 21:10 | 2005-05-18 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $2.00 | 498 | $996 | 6,893 | +7.8% |
| 2005-05-19 23:39 | 2005-05-17 | VCEL | Vericel Corp | ARMSTRONG R DOUGLAS PHD | Director, Officer; Chairman, CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $2.35 | 574,106 | $1,350,871 | 621,919 | -48.0% |
| 2005-04-22 20:56 | 2005-04-20 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $2.23 | 448 | $999 | 6,394 | +7.5% |
| 2005-03-18 23:08 | 2005-03-16 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $2.64 | 379 | $1,001 | 5,946 | +6.8% |
| 2005-03-05 01:17 | 2005-03-03 | VCEL | Vericel Corp | HAMPSON BRIAN | Officer; VP Product Develop | Biological Products, (No Diagnostic Substances) | OPT+S | $2.82 | 15,000 | $42,300 | 18,673 | -44.5% |
| 2005-02-25 01:28 | 2005-02-22 | VCEL | Vericel Corp | ARMSTRONG R DOUGLAS PHD | Director, Officer; Chairman and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $2.96 | 374,100 | $1,106,663 | 694,279 | -35.0% |
| 2005-02-19 00:29 | 2005-02-16 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $2.81 | 356 | $1,000 | 5,566 | +6.8% |
| 2005-01-22 00:34 | 2005-01-19 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $2.60 | 96 | $250 | 5,210 | +1.9% |
| 2004-12-23 23:35 | 2004-12-22 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $1.10 | 227 | $250 | 5,114 | +4.6% |
| 2004-11-19 23:22 | 2004-11-17 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $0.95 | 262 | $249 | 4,887 | +5.7% |
| 2004-10-22 21:32 | 2004-10-20 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $1.02 | 243 | $248 | 4,625 | +5.5% |
| 2004-09-24 20:48 | 2004-09-22 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $0.89 | 564 | $502 | 4,380 | +14.8% |
| 2004-08-24 23:46 | 2004-08-18 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $0.69 | 723 | $499 | 3,816 | +23.4% |
| 2004-07-23 23:15 | 2004-07-21 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $0.87 | 575 | $500 | 3,093 | +22.8% |
| 2004-07-23 23:03 | 2004-07-21 | VCEL | Vericel Corp | CAMPBELL MARY L | Director | Biological Products, (No Diagnostic Substances) | BUY | $0.87 | 287 | $250 | 1,633 | +21.3% |
| 2004-06-18 22:49 | 2004-06-16 | VCEL | Vericel Corp | FINGERLE LINDA M | Director | Biological Products, (No Diagnostic Substances) | BUY | $0.99 | 507 | $502 | 2,518 | +25.2% |
| 2004-06-18 23:01 | 2004-06-16 | VCEL | Vericel Corp | CAMPBELL MARY L | Director | Biological Products, (No Diagnostic Substances) | BUY | $0.99 | 254 | $251 | 1,346 | +23.3% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.